State Board Of Administration Of Florida Retirement System Esperion Therapeutics, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.7 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$2.02 - $3.02 $37,311 - $55,782	18,471 New	18,471 $49,000
Q4 2022 Feb 07, 2023	BUY	$5.09 - $8.5 $1,425 - $2,380	280 Added 1.54%	18,471 $115,000
Q2 2022 Aug 05, 2022	BUY	$4.77 - $6.67 $95 - $133	20 Added 0.11%	18,191 $116,000
Q2 2021 Aug 10, 2021	BUY	$19.4 - $28.71 $111,763 - $165,398	5,761 Added 46.42%	18,171 $384,000
Q1 2021 May 10, 2021	SELL	$25.12 - $36.89 $38,182 - $56,072	-1,520 Reduced 10.91%	12,410 $348,000
Q4 2020 Feb 08, 2021	SELL	$24.2 - $35.76 $16,214 - $23,959	-670 Reduced 4.59%	13,930 $362,000
Q3 2020 Nov 09, 2020	BUY	$31.18 - $52.71 $20,267 - $34,261	650 Added 4.66%	14,600 $543,000
Q4 2019 Feb 03, 2020	SELL	$35.4 - $59.82 $18,762 - $31,704	-530 Reduced 3.66%	13,950 $832,000
Q2 2019 Aug 05, 2019	BUY	$40.1 - $52.33 $125,112 - $163,269	3,120 Added 27.46%	14,480 $674,000
Q1 2019 May 03, 2019	BUY	$40.11 - $53.57 $10,428 - $13,928	260 Added 2.34%	11,360 $456,000
Q4 2018 Feb 01, 2019	BUY	$36.99 - $59.11 $26,965 - $43,091	729 Added 7.03%	11,100 $511,000
Q2 2018 Aug 06, 2018	BUY	$36.2 - $76.4 $22,806 - $48,132	630 Added 6.47%	10,371 $406,000
Q1 2018 May 04, 2018	BUY	$65.94 - $80.76 $25,123 - $30,769	381 Added 4.07%	9,741 $705,000
Q4 2017 Feb 01, 2018	BUY	$43.47 - $67.43 $17,388 - $26,972	400 Added 4.46%	9,360 $616,000
Q3 2017 Oct 31, 2017	BUY	$43.8 - $52.77 $392,448 - $472,819	8,960	8,960 $449,000

Others Institutions Holding ESPR

# of Institutions

214

Shares Held

128M

Call Options Held

1.78M

Put Options Held

1.27M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $99.8M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account